# Lactobacillus Farciminis and Hyperalgesia

> **NCT00852865** · PHASE1 · COMPLETED · sponsor: **Lallemand SAS** · enrollment: 48 (actual)

## Conditions studied

- Inflammation
- Pain

## Interventions

- **DRUG:** Lactobacillus farciminis
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00852865
- **Lead sponsor:** Lallemand SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2009-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00852865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00852865, "Lactobacillus Farciminis and Hyperalgesia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00852865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*